QuidelOrtho

QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer

Brings More Than Two Decades of Leadership Experience in the In-Vitro Diagnostics Industry SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and transfusion medicine, announced the Company’s Board of Directors (the “Board”) has appointed Brian J. Blaser as President and Chief Executive Officer (“CEO”) effective May 6. … Continue reading QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer

STAAR Surgical

STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

New Appointments Underscore Commitment to Driving Innovation and Industry-Leading Growth LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced Nancy Sabin has been named Chief Marketing Officer and Nathaniel Sisitsky has been named General Counsel. Both will serve on the Company’s executive committee … Continue reading STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel

Lucas Vitale

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

March 18, 2024 07:00 AM Eastern Daylight Time LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer. “I look forward to being a part of the team that will help further advance the company as we focus on continuous improvements … Continue reading Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

TecEx

TecEx Appoints Globally Recognised Revenue Leader as CPO

March 13, 2024 07:05 AM Eastern Daylight Time MAURITIUS–(BUSINESS WIRE)–Global technology supply chain market leader TecEx announces the appointment of Jeremy Dodds as Chief Partner Office & Head of Strategic Partnerships. Dodds joins TecEx bringing over 26 years of experience in the data center and channel partner space with companies including: Charles Schwab, Level 3 Communications, Equinix, and Digital Realty. Welcome Jeremy Dodds as Chief Partner Officer and Head of Strategic Partnerships to … Continue reading TecEx Appoints Globally Recognised Revenue Leader as CPO

QuidelOrtho

QuidelOrtho Announces Changes in Executive Leadership

The Board of Directors has terminated President and Chief Executive Officer, Douglas Bryant and appointed, on an interim basis, Michael Iskra as Chief Executive Officer and Robert Bujarski as President SAN DIEGO–(BUSINESS WIRE)–The Board of Directors (the “Board”) of QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) has made significant decisions aimed to enhance operational efficiency, drive revenue growth and deliver shareholder value. “All of … Continue reading QuidelOrtho Announces Changes in Executive Leadership

Amplitude Vascular Systems

AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Global executive will lead the clinical research strategy and execution for pulse intravascular lithotripsy BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs. She comes to AVS with more than two decades of leadership experience … Continue reading AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

CroíValve

CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

Additionally, Martin B. Leon, M.D. Appointed as Chair of its Clinical Advisory Board DUBLIN–(BUSINESS WIRE)– CroíValve, an Irish-U.S. based medical device company with a novel, transcatheter solution for tricuspid regurgitation (TR), today announced initiation of its Early Feasibility Study (EFS) for the DUO™ Tricuspid Coaptation Valve System, following FDA IDE and CMS approval. The TANDEM II trial is a prospective, multi-center, non-randomized single-arm study to … Continue reading CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

BIVACOR

BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia–(BUSINESS WIRE)–BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors. “A Total Artificial Heart (TAH) is unique in its complexity and importance as an advanced treatment option for end-stage biventricular heart failure patients. The … Continue reading BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer